Pages that link to "Q37200237"
Jump to navigation
Jump to search
The following pages link to ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. (Q37200237):
Displaying 50 items.
- Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism (Q24624234) (← links)
- Differential Effects of E2 on MAPK Activity in the Brain and Heart of Aged Female Rats (Q27332213) (← links)
- Priming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafil (Q28084015) (← links)
- Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale (Q28296128) (← links)
- The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities (Q28551385) (← links)
- The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes (Q28579371) (← links)
- Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats (Q28581703) (← links)
- Effects of sildenafil and/or muscle derived stem cells on myocardial infarction (Q30462352) (← links)
- PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells (Q33727865) (← links)
- Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts. (Q33865769) (← links)
- Are Phosphodiesterase Type 5 Inhibitors Associated with Vision-Threatening Adverse Events? A Critical Analysis and Review of the Literature (Q33965438) (← links)
- Hyperthermia differently affects connexin43 expression and gap junction permeability in skeletal myoblasts and HeLa cells. (Q34038093) (← links)
- Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats (Q34124879) (← links)
- Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats (Q34212259) (← links)
- Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction (Q34241307) (← links)
- cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action (Q34244951) (← links)
- Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection (Q34277031) (← links)
- Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice (Q34428464) (← links)
- Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis (Q34620765) (← links)
- Inhibition of ERK1/2 worsens intestinal ischemia/reperfusion injury (Q35000993) (← links)
- ZFP580, a novel zinc-finger transcription factor, is involved in cardioprotection of intermittent high-altitude hypoxia against myocardial ischemia-reperfusion injury (Q35145267) (← links)
- Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases. (Q35500693) (← links)
- PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer (Q35827798) (← links)
- Induction of cardioprotection by small netrin-1-derived peptides (Q35859191) (← links)
- Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation (Q35860938) (← links)
- Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation (Q35864123) (← links)
- Impact of Mitochondrial Ca2 -Sensitive Potassium (mBKCa) Channels in Sildenafil-Induced Cardioprotection in Rats (Q35869812) (← links)
- Overexpression of cGMP-dependent protein kinase I (PKG-I) attenuates ischemia-reperfusion-induced kidney injury (Q35964483) (← links)
- Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity (Q35999766) (← links)
- Cardioprotective actions of cyclic GMP: lessons from genetic animal models (Q36164755) (← links)
- Time-varying causal inference from phosphoproteomic measurements in macrophage cells (Q36243338) (← links)
- Sildenafil Protects against Myocardial Ischemia-Reperfusion Injury Following Cardiac Arrest in a Porcine Model: Possible Role of the Renin-Angiotensin System (Q36324656) (← links)
- Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. (Q36392865) (← links)
- Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury (Q36473769) (← links)
- Sildenafil promotes neuroprotection of the pelvic ganglia neurones after bilateral cavernosal nerve resection in the rat. (Q36542393) (← links)
- Role of the bradykinin B2 receptor in a rat model of local heart irradiation. (Q36552117) (← links)
- Serpinins: role in granule biogenesis, inhibition of cell death and cardiac function (Q36781898) (← links)
- Ginsenoside RK3 Prevents Hypoxia-Reoxygenation Induced Apoptosis in H9c2 Cardiomyocytes via AKT and MAPK Pathway (Q37015531) (← links)
- Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning cardioprotection in rats (Q37328645) (← links)
- The ERK1/2 signaling pathway is involved in sulfur dioxide preconditioning-induced protection against cardiac dysfunction in isolated perfused rat heart subjected to myocardial ischemia/reperfusion (Q37375425) (← links)
- Phosphodiesterase 5 inhibitors: are they cardioprotective? (Q37497840) (← links)
- Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart (Q37601041) (← links)
- Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells (Q37603936) (← links)
- Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK. (Q37714720) (← links)
- Phosphodiesterase Inhibition in Heart Failure (Q37893069) (← links)
- Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors (Q37903037) (← links)
- ROS and RNS Signaling in Heart Disorders: Could Antioxidant Treatment Be Successful? (Q37931014) (← links)
- Phosphodiesterases and cyclic GMP regulation in heart muscle (Q38033089) (← links)
- Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation. (Q38191314) (← links)
- Myocardial protection from ischemia-reperfusion injury post coronary revascularization (Q38552442) (← links)